UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000028009
Receipt No. R000032074
Scientific Title Examining effects of protein supplemetation on functional improvement during rehabilitaion intervention in chronic stroke patients
Date of disclosure of the study information 2017/06/30
Last modified on 2019/07/31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examining effects of protein supplemetation on functional improvement during rehabilitaion intervention in chronic stroke patients
Acronym Synergetic effects of exercise and protein supplementation for chronic stroke patients
Scientific Title Examining effects of protein supplemetation on functional improvement during rehabilitaion intervention in chronic stroke patients
Scientific Title:Acronym Synergetic effects of exercise and protein supplementation for chronic stroke patients
Region
Japan

Condition
Condition chronic stroke
Classification by specialty
Rehabilitation medicine Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Examining whether effects of exercise therapy and protein supplementation immediately after exercise on gait function, activities daily life (ADL), physical fitness, and blood volume during rehabilitaion in chronic stroke patients will be greater than those in placebo group.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Increases in plasma volume (albumine content), muscle strength of lower extremities, and cytokine level in blood
Key secondary outcomes aerobic capacity, Fugl-Meyer assessment, 6-min walking distance, and 10-m walking speed

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 From 1 to 4 weeks during hospitalization
5days/week
whey protein 0.1~0.2g/kg
Interventions/Control_2 From 1 to 4 weeks during hospitalization
5days/week
carbohydrate with similar calorie to supplementation durin intervention
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria 1) A patient whose onsets of stroke pass over 6 months
2) A patient who can walk by themselves with or without walking aids or braces
3) A patient who preserves communication ability
4) A patient whom a medical doctor approves for participating the present study
Key exclusion criteria 1) A patient who has lesions in the brainstem
2) A patient who has cardiovascular and respiratoly diseases which interferes gait function
instabilities of locomotory system
3) A patient who has a possibility for an instability of motor organs
4) A patient who has heaptic and/ or renal dsiorder
5) A patient who has a history of diabetes that poorly controlled.
6) A patient who has allergies of medicines
Target sample size 40

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoshi-ichiro Kamijo
Organization Wakayama Medical University
Division name Department of rehabilitation medicine
Zip code
Address 811-1 Kimiidera
TEL 073-441-0664
Email yoshikmj@gmail.com

Public contact
Name of contact person
1st name
Middle name
Last name Yoshi-ichiro Kamijo
Organization Wakayama Medical University
Division name Department of rehabilitation medicine
Zip code
Address 811-1 Kimiidera
TEL 073-441-0664
Homepage URL
Email yoshikmj@gmail.com

Sponsor
Institute Department of rehabilitation medicine,
Wakayama Medical University
Institute
Department

Funding Source
Organization Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 30 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 06 Month 16 Day
Date of IRB
2017 Year 06 Month 27 Day
Anticipated trial start date
2017 Year 06 Month 27 Day
Last follow-up date
2019 Year 02 Month 20 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2017 Year 06 Month 30 Day
Last modified on
2019 Year 07 Month 31 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032074

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.